Results 1 to 8 of 8
Page 1 of 1
TypeTitleAuthor(s)YearViews
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patientsHe, LR; Zhao, HY; Li, BK; Liu, YH; Liu, MZ; Guan, XY; Bian, XW; Zeng, YX; Xie, D2011160
 
EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β 1 and is a predictor of outcome in ovarian carcinoma patientsRao, ZY; Cai, MY; Yang, GF; He, LR; Mai, SJ; Hua, WF; Liao, YJ; Deng, HX; Chen, YC; Guan, XY; Zeng, YX; Kung, HF; Xie, D2010199
 
Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patientsHe, LR; Zhao, HY; Li, BK; Zhang, LJ; Liu, MZ; Kung, HF; Guan, XY; Bian, XW; Zeng, YX; Xie, D2010576
 
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapyHe, LR; Liu, MZ; Li, BK; Jia, WH; Zhang, Y; Liao, YJ; Chen, YC; Zhang, LJ; Guan, XY; Zeng, YX; Kung, HF; Xie, D2010486
 
Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinomaYang, GF; He, WP; Cai, MY; He, LR; Luo, JH; Deng, HX; Guan, XY; Zeng, MS; Zeng, YX; Xie, D2010603
 
Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.He, LR; Liu, MZ; Li, BK; Rao, HL; Deng, HX; Guan, XY; Zeng, YX; Xie, D2009116
 
Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinomaHe, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Zhang, LJ; Guan, XY; Zeng, YX; Xie, D2009123
 
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinomaHe, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Guan, XY; Zeng, YX; Xie, D2009188
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download